New bull's-eye for obesity fighting drugs
Drug developers have a new target to aim at in the fight against obesity after the discovery that a certain protein in the body stimulates the formation of fat cells.
Drug developers have a new target to aim at in the fight against obesity after the discovery that a certain protein in the body stimulates the formation of fat cells.
Several big drug-makers are voluntarily recalling some of their cough and cold products for under-two-year-olds in the US as a precautionary measure against overdosing on the drugs.
The first vaccine for travellers' diarrhoea is looking promising after the announcement of Phase II results.
Boehringer Ingelheim has been forced to announce the planned closure of a UK manufacturing site as a result of pricing pressures that mean the firm is unable to produce unit dose vials (UDVs) at the site cost-effectively.